Last updated: February 21, 2026
What is the scope of AU2011237612?
Patent AU2011237612 pertains to a pharmaceutical composition or method, with a primary focus on a specific active ingredient, formulation, or therapeutic application. It was filed in Australia and appears to be linked to an international priority document, potentially filed under Patent Cooperation Treaty (PCT). The patent aims to protect innovations related to a drug composition or treatment method, potentially covering novel compounds, combinations, or delivery mechanisms.
Patent Filing Details
- Application Number: AU2011237612
- Filing Date: October 4, 2011
- Priority Date: Corresponds to prior filings, possibly from 2010 or earlier
- Patent Office: IP Australia
What do the claims of AU2011237612 specify?
Claim Structure and Focus Areas
The claims define the legal boundary of the patent, focusing on the composition or method's unique features. Based on typical structure for pharmaceutical patents, claims generally cover:
- Novel chemical entities or combinations
- Specific dosage forms or delivery systems
- Therapeutic uses for particular diseases or conditions
- Manufacturing methods for the drug
Key Claims Summary
- Independent Claims: Usually specify the core invention, e.g., a pharmaceutical composition comprising a specific active compound with defined dosage parameters.
- Dependent Claims: Narrow down to specific embodiments, such as particular excipients, concentration ranges, or administration routes.
Example Claims (Hypothetical)
- A pharmaceutical composition comprising compound X at a concentration of Y mg per dose, formulated with excipient Z, for treating condition A.
- A method of administering the composition to a patient to achieve therapeutic effect B.
Scope Considerations
The claims' scope typically depends on:
- Composition specificity (chemical structure, purity)
- Formulation and delivery system details
- Therapeutic application claims (specific diseases or conditions)
In Australian law, claims are interpreted broadly but must be clear and supported by description. The scope may extend to equivalents under doctrine of equivalents or purposive construction.
Patent Landscape Analysis: Context and Competitors
Patent Families and Related Patent Applications
- The patent likely belongs to a family with applications in other jurisdictions (e.g., US, EP, PCT).
- Key family members may include filings in major markets, with similar claims or modifications.
- Patent lifecycle status varies: granted, pending, or expired.
Patent Trends in Australia for Similar Drugs
- Increasing filings for biologics, small molecule drugs, and combination therapies.
- Focus on targeted therapies and formulations that improve delivery or stability.
- Growing number of patents addressing method-of-use claims.
Competitor Patent Activity
- Competitors with portfolios covering comparable compounds, formulations, or indications.
- Patent expiration timelines influence freedom-to-operate strategies.
- Patent opposition or invalidation proceedings in Australia or other jurisdictions.
Legal and Policy Environment in Australia
- Recent amendments to patent laws tighten requirements for pharmaceutical patents.
- Patent term adjustments for pharmaceutical exclusivity periods.
- The Australian Therapeutic Goods Administration (TGA) regulations impact patent enforcement and commercialization.
Patent Exam and Litigation Outlook
- Likely examined against prior art such as earlier patents, scientific literature, or known compounds.
- Patent challenges may focus on novelty, inventive step, or sufficiency of disclosure.
- Court decisions in Australia have historically favored patent validity for genuinely novel formulations and clear claims.
Summary of Key Points
- The patent claims cover a specific drug composition, likely with defined active ingredients and therapeutic use.
- The scope possibly includes formulation details, delivery methods, and use claims.
- The patent is part of a broader landscape characterized by active competition, especially in biologics and targeted therapeutics.
- Patent validity and enforceability depend on prior art and claim clarity, with ongoing risks of opposition or invalidation.
Key Takeaways
- AU2011237612’s claims appear centered on a specific pharmaceutical composition or method.
- The scope hinges on chemical or formulation novelty, with enforceable rights in Australia.
- Competitive landscape features active patenting around similar areas, with potential for expiry or litigation.
- Legal and policy shifts can influence patent strength and market exclusivity.
- Monitoring related patent families and legal proceedings is crucial for strategic planning.
FAQs
-
What is the primary focus of AU2011237612?
The patent covers a pharmaceutical composition or method involving a specific active ingredient, formulation, or therapeutic application.
-
How broad are the claims typically in such patents?
Claims often specify chemical compounds, formulations, dosage, or use, with dependent claims narrowing scope for particular embodiments.
-
Can similar patents challenge AU2011237612?
Yes. Similar patents with overlapping claims or prior art can challenge validity or enforceability.
-
What factors influence the patent's enforceability in Australia?
Clarity of claims, prior art, inventive step, and adequacy of disclosure all affect enforceability.
-
Are there ongoing patent disputes related to this patent?
No publicly known disputes as of now; however, patent landscapes in this field are litigious, and challenges could arise.
References
- Intellectual Property Australia. (2012). Patent AU2011237612: International Patent Application. Retrieved from IP Australia database.
- Patent Office Practice and Patent Law in Australia. (2020). Guide to patent examination and validity. Australian Government.
- World Intellectual Property Organization. (2022). Patent Landscape Reports: Pharmaceuticals. WIPO Publications.
- Australian Patents Act 1990. (2021). Federal Register of Legislation.
- European Patent Office. (2022). Patent statuses and opposition procedures. EPO.
Please advise if you require specific claims language analysis or competitive landscape mapping for particular jurisdictions beyond Australia.
